{
    "2021-08-06": [
        [
            {
                "time": "",
                "original_text": "汇宇制药产能利用率或遭拔高 上亿元推广费异象迭起拷问交易真实性",
                "features": {
                    "keywords": [
                        "汇宇制药",
                        "产能利用率",
                        "推广费",
                        "交易真实性"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)携关联方各以不超500万美元认购双虹科技255.2万股B优先股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "双虹科技",
                        "优先股",
                        "关联交易"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)拟认购双虹科技新发行的B优先股255.2万股以追踪前沿新药开发技术",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "双虹科技",
                        "优先股",
                        "新药开发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：公司与杭州贝铭拟共同投资双虹科技",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "杭州贝铭",
                        "双虹科技",
                        "投资"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}